TranS1 (2)

TranS1 is a privately held medical device company specializing in minimally invasive spine surgery (MISS) technologies. Its core commercial products are the AxialLIF+ System for anterior lumbar interbody fusion at L5-S1 and the Vectre Facet Fusion System for posterior fixation, both designed to reduce muscle trauma and improve patient recovery. The company leverages a substantial body of clinical literature to support its products and focuses on surgeon training and education to drive adoption in the competitive spinal implant market.

A platform of specialized surgical instruments and implants enabling minimally invasive spinal fusion via unique anatomical approaches, primarily the pre-sacral axial route to L5-S1 (AxialLIF+) and a cannulated facet screw system for posterior fixation (Vectre).

TranS1 competes in the crowded spinal implants market against major players like Medtronic, Stryker, and Johnson & Johnson, who offer a wide range of MIS solutions. Its differentiation lies in its unique axial pre-sacral approach for L5-S1 fusion, competing against other MIS techniques such as lateral, oblique, and posterior approaches.